AccuStem Sciences, Inc.
ACUT
$0.388
$0.11240.58%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 21.50K | 71.00K | 120.70K | 180.60K | 734.00K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 108.40K | 181.60K | 332.00K | 60.20K | 168.40K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | 29.60K |
Total Current Assets | 129.80K | 252.60K | 452.70K | 240.80K | 932.00K |
|
|||||
Total Current Assets | 129.80K | 252.60K | 452.70K | 240.80K | 932.00K |
Net Property, Plant & Equipment | 4.00K | 5.00K | 5.90K | 6.80K | 7.70K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 133.90K | 257.60K | 458.50K | 247.60K | 939.70K |
|
|||||
Total Accounts Payable | 578.40K | 432.40K | 382.80K | 307.10K | 311.80K |
Total Accrued Expenses | 464.90K | 1.60M | 1.08M | 887.20K | 660.90K |
Short-term Debt | 55.70K | 112.80K | 297.90K | -- | 106.60K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 1.15M | -- | -- | -- | -- |
Total Other Current Liabilities | 1.15M | -- | -- | -- | -- |
Total Current Liabilities | 2.25M | 2.14M | 1.77M | 1.19M | 1.08M |
|
|||||
Total Current Liabilities | 2.25M | 2.14M | 1.77M | 1.19M | 1.08M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 55.70K | 112.80K | 297.90K | -- | 106.60K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.25M | 2.14M | 1.77M | 1.19M | 1.08M |
|
|||||
Common Stock & APIC | 4.41M | 4.39M | 4.37M | 4.36M | 4.33M |
Retained Earnings | -6.52M | -6.28M | -5.68M | -5.30M | -4.47M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -2.11M | -1.89M | -1.31M | -946.70K | -139.60K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -2.11M | -1.89M | -1.31M | -946.70K | -139.60K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.11M | -1.89M | -1.31M | -946.70K | -139.60K |
|